Authors: Wang D; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, 430030, Hubei, China.; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, 430030, Hubei, China., He L; Department of Hematology, Zhongnan Hospital, Wuhan University, Wuhan, 430071, Hubei, China., Li C; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, 430030, Hubei, China., Xu M; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, 430030, Hubei, China., Yu Q; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, 430030, Hubei, China., Almeida VDF; Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China., Que Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, 430030, Hubei, China., Xu Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, 430030, Hubei, China., Xiao Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, 430030, Hubei, China. yixiao@tjh.tjmu.edu.cn.; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, 430030, Hubei, China. yixiao@tjh.tjmu.edu.cn., Li C; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie-Fang Avenue, Wuhan, 430030, Hubei, China. cunrui5650@hust.edu.cn.; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, 430030, Hubei, China. cunrui5650@hust.edu.cn.

Source: BMC infectious diseases [BMC Infect Dis] 2023 Feb 22; Vol. 23 (1), pp. 109. Date of Electronic Publication: 2023 Feb 22.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE

Authors: Foglia E; Centre for Research on Health Economics, Social and Health Care Management, LIUC-Università Cattaneo, 21053 Castellanza, Italy., Garagiola E; Centre for Research on Health Economics, Social and Health Care Management, LIUC-Università Cattaneo, 21053 Castellanza, Italy., Ladisa V; Hospital Pharmacy, IRCCS National Cancer Institute Foundation, 20133 Milan, Italy., Rambaldi A; Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, 24127 Bergamo, Italy., Cairoli R; Division of Hematology, Grande Ospedale Metropolitano Niguarda Hospital, 20162 Milano, Italy., Sammassimo S; Department of Oncology and Hematology-Oncology, European Institute of Oncology, 20141 Milan, Italy., Salè EO; Hospital Pharmacy, European Institute of Oncology, 20141 Milan, Italy., Zinzani PL; Institute of Hematology 'Seragnoli', IRCCS University Hospital of Bologna, 40139 Bologna, Italy.; Department of Specialized, Diagnostic and Experimental Medicine, University of Bologna, 40139 Bologna, Italy., Esposti M; Management Control, Lodi Hospital, 26900 Lodi, Italy., Alberti L; Territorial Pharmaceutical Complex Structure, Regional Health Authority-ARES Sardinia, 09047 Cagliari, Italy., Mulas MF; General Direction, Policlinico Tor Vergata, 00133 Rome, Italy., Melis E; Complex Structure for Planning and Management Control, Regional Health Authority-ARES Sardinia, 07100 Sassari, Italy., Onnis S; Territorial District 3-Quartu Parteolla, Local Healthcare Authority-ASL 8, 09126 Cagliari, Italy., Marcias M; Complex Structure of Pharmacoeconomics and Pharmacovigilance, Regional Health Authority-ARES Sardinia, 09047 Cagliari, Italy., Satta V; Complex Structure Health Technology Assessment, Regional Health Authority-ARES Sardinia, 09047 Cagliari, Italy., Croce D; Centre for Research on Health Economics, Social and Health Care Management, LIUC-Università Cattaneo, 21053 Castellanza, Italy.

Source: International journal of environmental research and public health [Int J Environ Res Public Health] 2023 Feb 21; Vol. 20 (5). Date of Electronic Publication: 2023 Feb 21.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-4601 (Electronic) Linking ISSN: 16604601 NLM ISO Abbreviation: Int J Environ Res Public Health Subsets: MEDLINE

Authors: Sawaisorn P; Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand., Atjanasuppat K; Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand., Uaesoontrachoon K; Genepeutic Bio, Co. Ltd., Bangkok, Thailand., Rattananon P; Genepeutic Bio, Co. Ltd., Bangkok, Thailand., Treesuppharat W; Thammasat University Research Unit in Mechanisms of Drug Action and Molecular Imaging, Drug Discovery and Development Center, Office of Advanced Science and Technology, Thammasat University, Pathum Thani, Thailand., Hongeng S; Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand., Anurathapan U; Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Source: PloS one [PLoS One] 2023 Feb 13; Vol. 18 (2), pp. e0281735. Date of Electronic Publication: 2023 Feb 13 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Authors: Liu Q; Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China., Li J; Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China., Zheng H; Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China., Yang S; Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China., Hua Y; Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China., Huang N; Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China., Kleeff J; Department of Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Halle-Wittenberg, 06120, Halle (Saale), Germany., Liao Q; Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China. lqpumc@126.com., Wu W; Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuai Fu Yuan, Dongcheng District, Beijing, 100730, China. wuwm@pumch.cn.

Source: Molecular cancer [Mol Cancer] 2023 Feb 07; Vol. 22 (1), pp. 28. Date of Electronic Publication: 2023 Feb 07.

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

Authors: Maalej KM; Translational Cancer Research Facility, National Center for Cancer Care and Research, Translational Research Institute, Hamad Medical Corporation, P.O. Box: 3050, Doha, Qatar., Merhi M; Translational Cancer Research Facility, National Center for Cancer Care and Research, Translational Research Institute, Hamad Medical Corporation, P.O. Box: 3050, Doha, Qatar. mmerhi@hamad.qa., Inchakalody VP; Translational Cancer Research Facility, National Center for Cancer Care and Research, Translational Research Institute, Hamad Medical Corporation, P.O. Box: 3050, Doha, Qatar., Mestiri S; Translational Cancer Research Facility, National Center for Cancer Care and Research, Translational Research Institute, Hamad Medical Corporation, P.O. Box: 3050, Doha, Qatar., Alam M; Translational Research Institute, Academic Health System, Dermatology Institute, Hamad Medical Corporation, Doha, Qatar.; Department of Dermatology and Venereology, Hamad Medical Corporation, Doha, Qatar., Maccalli C; Laboratory of Immune and Biological Therapy, Research Department, Sidra Medicine, Doha, Qatar., Cherif H; Department of Hematology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Uddin S; Translational Research Institute, Academic Health System, Dermatology Institute, Hamad Medical Corporation, Doha, Qatar., Steinhoff M; Translational Research Institute, Academic Health System, Dermatology Institute, Hamad Medical Corporation, Doha, Qatar.; Department of Dermatology and Venereology, Hamad Medical Corporation, Doha, Qatar.; Department of Dermatology, Weill Cornell Medicine-Qatar, Doha, Qatar.; College of Medicine, Qatar University, Doha, Qatar.; Department of Dermatology, Weill Cornell Medicine, New York, USA., Marincola FM; Global Head of Research, Kite Pharma, Santa Monica, California, USA., Dermime S; Translational Cancer Research Facility, National Center for Cancer Care and Research, Translational Research Institute, Hamad Medical Corporation, P.O. Box: 3050, Doha, Qatar. sdermime@hamad.qa.; College of Health and Life Sciences (CHLS), Hamad Bin Khalifa University, Doha, Qatar. sdermime@hamad.qa.

Source: Molecular cancer [Mol Cancer] 2023 Jan 30; Vol. 22 (1), pp. 20. Date of Electronic Publication: 2023 Jan 30.

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

Authors: Gabandé-Rodríguez E; Departamento de Biología Molecular, Facultad de Ciencias (UAM), Centro de Biología Molecular 'Severo Ochoa' (CSIC-UAM), Universidad Autónoma de Madrid, Madrid, Spain.; Instituto de Investigación Sanitaria del Hospital 12 de Octubre (i+12), Madrid, Spain., Pfeiffer M; Departamento de Biología Molecular, Facultad de Ciencias (UAM), Centro de Biología Molecular 'Severo Ochoa' (CSIC-UAM), Universidad Autónoma de Madrid, Madrid, Spain., Mittelbrunn M; Instituto de Investigación Sanitaria del Hospital 12 de Octubre (i+12), Madrid, Spain.; Consejo Superior de Investigaciones Científicas (CSIC), Centro de Biología Molecular 'Severo Ochoa' (CSIC-UAM), Universidad Autónoma de Madrid, Madrid, Spain.

Source: EMBO molecular medicine [EMBO Mol Med] 2023 Jan 11; Vol. 15 (1), pp. e16301. Date of Electronic Publication: 2022 Nov 14.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE

Authors: Liu Z; Department of Neurosurgery, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Centre, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.; The Third School of Clinical Medicine, Southern Medical University, Shenzhen, Guangdong, China.; Department of Neurosurgery, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China., Zhou J; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Centre, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.; The Third School of Clinical Medicine, Southern Medical University, Shenzhen, Guangdong, China., Yang X; Department of Neurosurgery, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.; The Third School of Clinical Medicine, Southern Medical University, Shenzhen, Guangdong, China.; Department of Neurosurgery, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China., Liu Y; Shenzhen Geno-Immune Medical Institute, Shenzhen, Guangdong, China., Zou C; School of Medicine, Life and Health Sciences, The Chinese University of Hong Kong (Shenzhen), Shenzhen, Guangdong, China., Lv W; Department of Neurosurgery, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China., Chen C; Department of Neurosurgery, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China., Cheng KK; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China., Chen T; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Centre, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.; The Third School of Clinical Medicine, Southern Medical University, Shenzhen, Guangdong, China., Chang LJ; Shenzhen Geno-Immune Medical Institute, Shenzhen, Guangdong, China. c@szgimi.org., Wu D; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Centre, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China. wudinglan123@smu.eud.com.; The Third School of Clinical Medicine, Southern Medical University, Shenzhen, Guangdong, China. wudinglan123@smu.eud.com., Mao J; Department of Neurosurgery, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China. myw921@yahoo.com.

Source: Molecular cancer [Mol Cancer] 2023 Jan 09; Vol. 22 (1), pp. 3. Date of Electronic Publication: 2023 Jan 09.

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

Authors: Lonial S; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.; Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.

Source: Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2023 Jan; Vol. 21 (1), pp. 43-45.

Publication Type: Interview

Journal Info: Publisher: Millennium Medical Pub Country of Publication: United States NLM ID: 101167661 Publication Model: Print Cited Medium: Internet ISSN: 1543-0790 (Print) Linking ISSN: 15430790 NLM ISO Abbreviation: Clin Adv Hematol Oncol Subsets: MEDLINE

Authors: Kapinos KA; Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Harold C. Simmons Comprehensive Cancer Center, 12334University of Texas Southwestern Medical Center, Dallas, TX, USA.; RAND Corporation, Arlington, VA, USA., Hu E; Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA., Trivedi J; Department of Pharmacy, 12334University of Texas Southwestern Medical Center, Dallas 75390-9096, TX, USA., Geethakumari PR; Division of Hematologic Malignancies and Cellular Therapy, Department of Internal Medicine, 12334University of Texas Southwestern Medical Center, Dallas, TX, USA., Kansagra A; Harold C. Simmons Comprehensive Cancer Center, 12334University of Texas Southwestern Medical Center, Dallas, TX, USA.; Division of Hematologic Malignancies and Cellular Therapy, Department of Internal Medicine, 12334University of Texas Southwestern Medical Center, Dallas, TX, USA.

Source: Cancer control : journal of the Moffitt Cancer Center [Cancer Control] 2023 Jan-Dec; Vol. 30, pp. 10732748221142945.

Publication Type: Journal Article

Journal Info: Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9438457 Publication Model: Print Cited Medium: Internet ISSN: 1526-2359 (Electronic) Linking ISSN: 10732748 NLM ISO Abbreviation: Cancer Control Subsets: MEDLINE

Authors: Larkin H

Source: JAMA [JAMA] 2022 Dec 13; Vol. 328 (22), pp. 2201.

Publication Type: Journal Article

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

Authors: Caruso S; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., De Angelis B; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy. biagio.deangelis@opbg.net., Del Bufalo F; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Ciccone R; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Donsante S; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy., Volpe G; Research Laboratories, Bambino Gesù Children's Hospital, IRCCS, 00146, Rome, Italy., Manni S; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Guercio M; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Pezzella M; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Iaffaldano L; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Silvestris DA; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Sinibaldi M; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Di Cecca S; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Pitisci A; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Velardi E; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Merli P; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Algeri M; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Lodi M; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Paganelli V; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy., Serafini M; Department of Pediatrics, Tettamanti Research Center, Fondazione MBBM/San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy., Riminucci M; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy., Locatelli F; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy. franco.locatelli@opbg.net.; Department of Life Science and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy. franco.locatelli@opbg.net., Quintarelli C; Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Source: Journal of hematology & oncology [J Hematol Oncol] 2022 Nov 05; Vol. 15 (1), pp. 163. Date of Electronic Publication: 2022 Nov 05.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

Authors: Nakajima K; Laboratory of Cell Vaccine, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki-shi, Osaka, Japan., Shen Z; Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, Bunkyo-ku, Tokyo, Japan., Miura M; Laboratory of Cell Vaccine, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki-shi, Osaka, Japan., Nakabayashi H; Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, Bunkyo-ku, Tokyo, Japan., Kawahara M; Laboratory of Cell Vaccine, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki-shi, Osaka, Japan.; Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.

Source: PloS one [PLoS One] 2022 Dec 27; Vol. 17 (12), pp. e0279409. Date of Electronic Publication: 2022 Dec 27 (Print Publication: 2022).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Authors: Shah BD; Moffitt Cancer Center, Tampa, FL, 33612, USA. bijal.shah@moffitt.org., Ghobadi A; Washington University School of Medicine, St Louis, MO, USA., Oluwole OO; Vanderbilt University Cancer Center, Nashville, TN, USA., Logan AC; UCSF Medical Center, San Francisco, CA, USA., Boissel N; Hôpital Saint-Louis, Paris, France., Cassaday RD; University of Washington, Fred Hutchinson Cancer Center, Seattle, WA, USA., Leguay T; Service d'hématologie Clinique Et Thérapie Cellulaire, Hopital du Haut-Leveque CHU de Bordeaux, Bordeaux, France., Bishop MR; The University of Chicago Medicine, Chicago, IL, USA., Topp MS; Medizinische Klinik Und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany., Tzachanis D; University of California San Diego, San Diego, CA, USA., O'Dwyer KM; Wilmot Cancer Institute of University of Rochester, Rochester, NY, USA., Arellano ML; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Lin Y; Mayo Clinic, Rochester, MN, USA., Baer MR; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Schiller GJ; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Park JH; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Subklewe M; Ludwig-Maximilians-Universität München, Munich, Germany., Abedi M; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA., Minnema MC; University Medical Center Utrecht (on behalf of HOVON/LLPC), Utrecht, The Netherlands., Wierda WG; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., DeAngelo DJ; Dana-Farber Cancer Institute, Boston, MA, USA., Stiff P; Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA., Jeyakumar D; University of California Irvine Medical Center, Orange, CA, USA., Dong J; Kite, a Gilead Company, Santa Monica, CA, USA., Adhikary S; Kite, a Gilead Company, Santa Monica, CA, USA., Zhou L; Kite, a Gilead Company, Santa Monica, CA, USA., Schuberth PC; Kite, a Gilead Company, Santa Monica, CA, USA., Faghmous I; Kite, a Gilead Company, Santa Monica, CA, USA., Masouleh BK; Kite, a Gilead Company, Santa Monica, CA, USA., Houot R; CHU Rennes, Univ Rennes, Inserm & EFS, Rennes, France.

Source: Journal of hematology & oncology [J Hematol Oncol] 2022 Dec 10; Vol. 15 (1), pp. 170. Date of Electronic Publication: 2022 Dec 10.

Publication Type: Multicenter Study; Journal Article

Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

Authors: Chacim S; Department of Onco-hematology, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal.; Cancer Biology and Epigenetics Group, Portuguese Oncology Institute of Porto Research Center (CI-IPOP) / RISE@CI-IPOP (Health Research Network) / Porto Comprehensive Cancer Center (Porto.CCC), Porto, Portugal., Monjardino T; Cancer Epidemiology Group, Portuguese Oncology Institute of Porto Research Center (CI-IPOP) / RISE@CI-IPOP (Health Research Network) / Porto Comprehensive Cancer Center (Porto.CCC), Porto, Portugal., Cunha JL; Outcomes Research Lab, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal.; Management, Outcomes Research, and Economics in Healthcare Group, Portuguese Oncology Institute of Porto Research Center (CI-IPOP) / RISE@CI-IPOP (Health Research Network) / Porto Comprehensive Cancer Center (Porto.CCC), Porto, Portugal., Medeiros P; Outcomes Research Lab, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal.; Management, Outcomes Research, and Economics in Healthcare Group, Portuguese Oncology Institute of Porto Research Center (CI-IPOP) / RISE@CI-IPOP (Health Research Network) / Porto Comprehensive Cancer Center (Porto.CCC), Porto, Portugal.; Medicine and Oncological Medicine Departments Management, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal., Redondo P; Outcomes Research Lab, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal.; Management, Outcomes Research, and Economics in Healthcare Group, Portuguese Oncology Institute of Porto Research Center (CI-IPOP) / RISE@CI-IPOP (Health Research Network) / Porto Comprehensive Cancer Center (Porto.CCC), Porto, Portugal., Bento MJ; Cancer Epidemiology Group, Portuguese Oncology Institute of Porto Research Center (CI-IPOP) / RISE@CI-IPOP (Health Research Network) / Porto Comprehensive Cancer Center (Porto.CCC), Porto, Portugal.; Department of Epidemiology, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal.; Department of Population Studies, ICBAS-School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), Porto, Portugal., Mariz JM; Department of Onco-hematology, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal.

Source: PloS one [PLoS One] 2022 Dec 09; Vol. 17 (12), pp. e0278950. Date of Electronic Publication: 2022 Dec 09 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Authors: Xia Y; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China., Zhang J; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China., Li J; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China., Zhang L; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China., Li J; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China., Fan L; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China., Chen L; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.

Source: Annals of medicine [Ann Med] 2022 Dec; Vol. 54 (1), pp. 2951-2965.

Publication Type: Meta-Analysis; Systematic Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8906388 Publication Model: Print Cited Medium: Internet ISSN: 1365-2060 (Electronic) Linking ISSN: 07853890 NLM ISO Abbreviation: Ann Med Subsets: MEDLINE

Authors: Wu LS; Janssen Research & Development, Brisbane, California, USA., Su Y; Janssen Research and Development, Raritan, New Jersey, USA., Li C; Janssen Research and Development, Spring House, Pennsylvania, USA., Zhou W; Janssen Research and Development, Spring House, Pennsylvania, USA., Jackson CC; Janssen Research and Development, Raritan, New Jersey, USA., Sun YN; Janssen Research and Development, Spring House, Pennsylvania, USA.; Cognigen Division, Simulations Plus, Buffalo, New York, USA., Zhou H; Janssen Research and Development, Spring House, Pennsylvania, USA.; Elevar Therapeutics, Salt Lake City, Utah, USA.

Source: Clinical and translational science [Clin Transl Sci] 2022 Dec; Vol. 15 (12), pp. 3000-3011. Date of Electronic Publication: 2022 Oct 06.

Publication Type: Journal Article

Journal Info: Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE

Authors: Tian J; School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China., Bai T; School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China., Zhang Z; School of Basic Medicine, Shandong First Medical University, Jinan, China., Zhai X; School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China., Wang K; School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China., Gao X; School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China., Yan B; School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.

Source: Journal of cancer research and therapeutics [J Cancer Res Ther] 2022 Dec; Vol. 18 (7), pp. 1867-1875.

Publication Type: Journal Article; Review

Journal Info: Publisher: Medknow Publications Country of Publication: India NLM ID: 101249598 Publication Model: Print Cited Medium: Internet ISSN: 1998-4138 (Electronic) Linking ISSN: 19984138 NLM ISO Abbreviation: J Cancer Res Ther Subsets: MEDLINE

Transliterated Title: Praktické aspekty terapie CAR-T lymfocyty.

Authors: Jana M, Tomáš J, Michal K, Kateřina B, Juraj U, Ivo D, Zdeněk K, Roman H

Source: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti [Klin Onkol] 2022 Winter; Vol. 35 (1), pp. 44-54.

Publication Type: Journal Article; Review

Journal Info: Publisher: Ceská lékarská spolecnost Country of Publication: Czech Republic NLM ID: 9425213 Publication Model: Print Cited Medium: Internet ISSN: 1802-5307 (Electronic) Linking ISSN: 0862495X NLM ISO Abbreviation: Klin Onkol Subsets: MEDLINE

Authors: Ying PT; Department of Hematology-Oncology, The Children's Hospital, Zhejiang University School of Medicine, Pediatric Leukemia Diagnostic and Therapeutic Technology Research Center of Zhejiang Province, National Clinical Research Center for Child Health, Hangzhou 310003, Zhejiang Province, China., Weng WW; Department of Hematology-Oncology, The Children's Hospital, Zhejiang University School of Medicine, Pediatric Leukemia Diagnostic and Therapeutic Technology Research Center of Zhejiang Province, National Clinical Research Center for Child Health, Hangzhou 310003, Zhejiang Province, China., Tang YM; Department of Hematology-Oncology, The Children's Hospital, Zhejiang University School of Medicine, Pediatric Leukemia Diagnostic and Therapeutic Technology Research Center of Zhejiang Province, National Clinical Research Center for Child Health, Hangzhou 310003, Zhejiang Province, China .E-mail: y_m_tang@zju.edu.cn.

Source: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2022 Dec; Vol. 30 (6), pp. 1902-1906.

Publication Type: Review; English Abstract; Journal Article

Journal Info: Publisher: Zhongguo shi yan xue za zhi she Country of Publication: China NLM ID: 101084424 Publication Model: Print Cited Medium: Print ISSN: 1009-2137 (Print) Linking ISSN: 10092137 NLM ISO Abbreviation: Zhongguo Shi Yan Xue Ye Xue Za Zhi Subsets: MEDLINE

Authors: Iovino L; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Wu QV; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Voutsinas J; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Panaite L; Department of Medicine, University of Washington, Seattle, Washington, USA., Mullane E; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Lynch RC; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Ujjani C; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Smith SD; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Gopal AK; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Till BG; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Milano F; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Chow V; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Gauthier J; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Turtle CJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Maloney DG; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Shadman M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.

Source: Journal of cellular and molecular medicine [J Cell Mol Med] 2022 Dec; Vol. 26 (24), pp. 5976-5983. Date of Electronic Publication: 2022 Dec 01.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1582-4934 (Electronic) Linking ISSN: 15821838 NLM ISO Abbreviation: J Cell Mol Med Subsets: MEDLINE